Research from the International Cancer Benchmarking Partnership has found a link between cancer policy consistency over time and survival for six cancer types

Research from our Cambridge Institute has shown us that metastasis isn’t a process unique to cancer, revolutionising the way we think about cell dissemination. 

A team of researchers has developed a new tool to identify mutational signatures in cancer DNA that’s quickly establishing itself as the best of the best.  

One of our interpreted Talk Cancer workshops has been recognised in the Royal Society of Public Health’s, Health and Wellbeing awards 2022.

In the last 2 years, our partner, the Nepal Development Research Institute, have successfully advocated for increases in tobacco tax in Nepal.

Today, the UK National Screening Committee has recommended introducing a targeted lung cancer screening programme across the UK, for those…

In this instalment of our Health Inequalities series, we take a look at some of the barriers that can make it harder for some people to access cancer screening.

We spoke to Dr Debbie Hicks about what is being done to understand and minimise the impact of long-term side effects for children and young people with medulloblastoma.

In an unusual turn of events, the results of a clinical trial for mitoxantrone turned out to be so effective that the randomisation of the trial was halted early. 

Focusing on cancer prevention globally is essential; we cannot say we have beaten cancer until we have beaten it everywhere.